Source: International Congress 2019 – Airway disease-associated exacerbations
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Fahey (London, United Kingdom), W. Meeraus (London, United Kingdom), C. El Baou (London, United Kingdom), H. Mullerova (London, United Kingdom), E. M. Hessel (London, United Kingdom), W. A. Fahy (London, United Kingdom). Factors associated with prolonged duration of AECOPD:Analysis of the ECLIPSE cohort. 4282

Member's Comments

No comment yet.

Related content which might interest you: Markers of disease activity in COPD: an 8-year mortality study in the ECLIPSE cohort Source: Eur Respir J, 57 (3) 2001339; 10.1183/13993003.01339-2020 Year: 2021 Predicting early vs late vs no re-exacerbation in COPD patients:Analysis of ECLIPSE cohort Source: International Congress 2019 – Exacerbations of airway diseases Year: 2019 Factors associated with exacerbations in patients with COPD: NOVELTY study Source: Virtual Congress 2020 – COPD and the impact of comorbidities Year: 2020 One-year exacerbation frequency and treatment in the ECLIPSE study cohort Source: Annual Congress 2009 - COPD: exacerbation and clinical problems Year: 2009 Factors acting on the duration of hospitalization in COPD Source: International Congress 2017 – What is new in COPD diagnosis and classification? Year: 2017 External validation of two prognostic scores predicting exacerbations in ECLIPSE COPD patients Source: Virtual Congress 2020 – Airflow obstruction, COPD and comorbidities Year: 2020 Identification of factors associated with exacerbation risk in severe COPD: Multivariate analysis of the WISDOM study Source: International Congress 2016 – Pharmacological management of COPD Year: 2016 Factors associated with exacerbations in US patients with COPD Source: Annual Congress 2009 - Exacerbations and characteristics of COPD Year: 2009 Factors associated with one-year mortality in hospitalized patients with exacerbation of bronchiectasis. Source: Virtual Congress 2020 – New investigations of bronchiectasis and non-tuberculous mycobacteria Year: 2020 Estimation of a disease progression model for COPD using data from the ECLIPSE study Source: Annual Congress 2013 –Health economics of airway diseases Year: 2013 Frequency of exacerbations in patients with COPD: an analysis of the SPIROMICS cohort Source: International Congress 2017 – COPD: latest insights into the management of patients Year: 2017 Factors associated with mortality in the TORCH trial in COPD Source: Eur Respir J 2007; 30: Suppl. 51, 356s Year: 2007 One-year survival in patients hospitalized due to an acute exacerbation of COPD. Related factors Source: Annual Congress 2009 - COPD: exacerbation and clinical problems Year: 2009 Factors associated with COPD exacerbation frequency in a UK primary care cohort Source: Annual Congress 2013 –Risk factors for COPD and lung function decline Year: 2013 Risk factors of re-hospitalisation for a COPD exacerbation: a prospective study Source: Eur Respir J 2002; 20: Suppl. 38, 402s Year: 2002 COPD exacerbation admissions: Analysis of demographics and mortality Source: Annual Congress 2013 –COPD treatment Year: 2013 Factors associated with physician assessment of severity of asthma or COPD in NOVELTY Source: Virtual Congress 2020 – New tools for diagnosis of obstructive diseases Year: 2020 Persistence of clinical criteria of chronic bronchitis in patients with COPD over time: A longitudinal analysis of the TRACE cohort. Source: International Congress 2017 – Markers of COPD progression Year: 2017 Factors affecting survival after severe COPD exacerbations: a single-center experience. Source: Virtual Congress 2020 – COPD and the impact of comorbidities Year: 2020 Clinical and demographic factors associated with pneumonia risk in a COPD patient cohort Source: International Congress 2015 – The relevance of diagnostic and monitoring tools in clinical practice Year: 2015